New Key Statistics Module, Z-Score and F-Score
OTCPK:CSBTF Key Ratios
| Market Cap $ M | 870.96 |
| Enterprise Value $ M | 871.29 |
| P/E(ttm) | 96.36 |
| PE Ratio without NRI | 100.74 |
| Forward PE Ratio | 76.38 |
| Price/Book | 9.80 |
| Price/Sales | 5.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 174.00 |
| EPS (TTM) $ | 0.23 |
| Beneish M-Score | -1.84 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 688.20 |
| EV-to-EBIT | 131.38 |
| EV-to-EBITDA | 131.38 |
| PEG | -- |
| Shares Outstanding M | 39.67 |
| Net Margin (%) | 5.13 |
| Operating Margin % | 6.07 |
| Pre-tax Margin (%) | 6.15 |
| Quick Ratio | 1.28 |
| Current Ratio | 1.87 |
| ROA % (ttm) | 6.81 |
| ROE % (ttm) | 10.68 |
| ROIC % (ttm) | 8.44 |
| Dividend Yield % | -- |
| Altman Z-Score | 12.13 |
CSBTF Number of Guru Trades
CSBTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CSBTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CSBTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kuros Biosciences Ltd Insider Transactions
No Available Data
News about OTCPK:CSBTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers